The aim of this study was to develop a PCR and reverse line blot hybridization (PCR-RLB) macroarray assay based on 16S-23S rRNA gene internal transcribed spacer sequences for the identification and differentiation of 34 mycobacterial species or subspecies. The performance of the PCR-RLB assay was assessed and validated by using 78 reference strains belonging to 55 Mycobacterium species, 219 clinical isolates which had been identified as mycobacteria by high-performance liquid chromatography or gas chromatography, three skin biopsy specimens from patients with suspected leprosy which had been shown to contain acid-fast bacilli, and isolates of 14 nonmycobacterial species. All mycobacteria were amplified in the PCR and hybridized with a genus-specific probe (probe MYC). The 34 species-specific probes designed in this study hybridized only with the corresponding Mycobacterium species. The mycobacterial PCR-RLB assay is an efficient tool for the identification of clinical isolates of mycobacteria; it can reliably identify mixed mycobacterial cultures and M. leprae in skin biopsy specimens.
Mycobacterium tuberculosis infection continues to increase worldwide at an estimated annual rate of 3.5% (http://www .who.int/tb/publications/global_report/2005/pdf/Full.pdf). The rapidly spreading human immunodeficiency virus (HIV) epidemic in many parts of the world will further increase the number of HIV-related cases of tuberculosis as well as the number of nontuberculous mycobacterial infections. The rapid and accurate identification of clinically significant mycobacterial species is necessary for optimal medical and public health interventions (3, 21) .
The results of traditional methods for the identification of closely related Mycobacterium species by growth characteristics (pigment, growth rate, colonial morphology) and biochemical tests are often difficult to interpret, even for some very common species. The tests are cumbersome and time-consuming, require expertise, lack sensitivity and reproducibility (21) , and often use nonstandardized reagents. Rapid biochemical methods, such as high-performance liquid chromatography (HPLC) of mycolic acids and gas chromatography (GC) of fatty acids, are available only in specialized laboratories (2) .
The rapid identification of mycobacteria to the species level is recommended in clinical laboratories to ensure accurate diagnosis and effective therapy. This has stimulated the development in recent years (1, 4-9, 11-20, 22, 25, 29, 30 ) of a number of rapid and more accurate identification tools based on molecular technology.
Several DNA sequences or genes have been targeted for the differentiation of Mycobacterium species, including the 16S rRNA gene (8, 9) , the 23S rRNA gene (13, 15) , the 16S-23S rRNA gene spacer region (15) , the 32-kDa protein gene (22) , dnaA (14) , dnaJ (25) , gyrB (4) , recA (1), rpoB (6, 17) , secA1 (29) , and sod (30) . There are at least two commercially available systems for the identification of Mycobacterium spp. based on line probe hybridization, namely, the INNO-LiPA Mycobacterium system (Immunogenetics, Ghent, Belgium), which targets the 16S-23S rRNA gene spacer region and which identifies 16 Mycobacterium species, and the GenoType Mycobacterium CM/AS system (Hain Life Science, Nehren, Germany), which targets the 23S rRNA gene and which identifies 13 species (14) . None of these methods can differentiate all of the Mycobacterium species commonly isolated in the clinical laboratory; more discriminatory methods are still needed for clinical and epidemiological investigations.
In this study, we developed a PCR-reverse line blot hybridization (PCR-RLB) assay based on the 16S-23S rRNA gene internal transcribed spacers (ITSs) for the identification of a larger number of mycobacteria to the species or the subspecies level. patients. Skin biopsy specimens from three patients with presumed leprosy which had been shown to contain acid-fast bacilli by microscopy were included in the study. Mycobacteria were grown on Löwenstein-Jensen (L-J) slants with weekly inspection until visible growth was detected or in 7H12 broth (MGIT liquid medium; Becton Dickinson) until a positive growth index was signaled by the automated system. Colonies were scraped from the L-J slants and suspended in 1 ml Tris-HCl buffer (10 mM; pH 7.5). The bacteria were killed by heating them to 100°C for 30 min and were then stored at 4°C. The clinical isolates used had been identified to the species level by standard biochemical procedures, and their identities were confirmed by HPLC (CIDM isolates) or GC (isolates from both Chinese laboratories) (2) .
Probe and primer design. Primers Sp1 (5Ј-ACC TCC TTT CTA AGG AGC ACC-3Ј) and Sp2 (5Ј-GAT GCT CGC AAC CAC TAT YCA-3Ј), which target the 16S-23S ITS region of the M. tuberculosis spacer sequence (GenBank accession number L15623), were modified from a previous publication (19) ; 35 species-specific probes based on the published 16S-23S ITS sequences of various Mycobacterium species were designed ( Table 2 ). All probes and primers were checked for specificity against all sequences in GenBank by using QueryBD, WebANGIS GCG, SeqSearch, and Browse code in the Australian National Genomic Information Services (ANGIS) programs (http://www1.angis.org.au /WebANGIS/WebFM). The probes were designed to have similar melting temperatures above 62°C, and their lengths varied from 20 bp to 27 bp. All oligonucleotide probes and primers were synthesized with a 5Ј-terminal amino group and biotin labels (Sigma-Aldrich, St. Louis, Mo.), respectively. DNA extraction and PCR amplification. The extraction of DNA was carried out with a commercially available kit (InstaGene Matrix; Bio-Rad Laboratories), according to the manufacturer's specifications. Amplification of an ITS segment was performed with primers Sp1 and Sp2 in a 25-l reaction mixture containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 0.1% Triton X-100, 200 M (each) deoxynucleoside triphosphate (dATP, dGTP, dCTP, and dUTP), 25 pmol of each primer, 0.75 U of Taq DNA polymerase (all reagents were from QIAGEN, Pty. Ltd., Australia), and 5 l of DNA. The thermal profile involved initial denaturation for 5 min at 96°C and 35 cycles with the following steps: 30 s of denaturation at 94°C, 30 s of annealing at 60°C, and 1 min of extension at 72°C. The final extension was for 10 min at 72°C. The PCR products were analyzed with SRBR Safe DNA gel stain (Molecular Probes Europe BV, The Netherlands).
Nucleotide sequencing. The purified PCR products were directly sequenced with forward primers Sp1 and Sp2 by using an Applied Biosystems model 373A DNA sequencer (Perkin-Elmer Applied Biosystems) and a BigDye Terminator cycle sequencing kit. Sequences were identified by using the FastA program group accessed through WebANGIS.
RLB assay. The RLB assay was performed by using a system which has previously been described in detail (28, 31) . Briefly, the slots in a Miniblotter 45 apparatus (Immunetics) were filled with 150 l of optimized concentrations of probe solution. Each PCR product was denatured and immediately chilled on ice. Hybridization was performed at 60°C for 40 min. The washed membrane was incubated in peroxidase-labeled streptavidin conjugate (Roche, Mannheim, Germany) at 42°C for 40 min. The washed membrane was then incubated in chemiluminescence blotting substrate (ECL Direct system; Roche) for 1 min, covered with Hyperfilm X-ray film (Amersham) for detection of chemiluminescence, and exposed to the X-ray film for 7 min.
Sensitivities of species-specific PCR and ITS PCR-RLB assay. M. tuberculosis H37Rv and M. abscessus stock suspensions were prepared from cultures after 2 and 3 weeks of growth, respectively, on Löwenstein-Jensen slants and adjusted to a 0.5 McFarland standard. DNA was extracted as described above. The detection limits of the individual species-specific PCR and the PCR-RLB assay were determined by amplification and hybridization of the DNA of each species serially diluted from 5 ng/l to 500 fg/l with molecular biology-grade water and tested in parallel.
RESULTS

Sensitivities of PCR-RLB assay.
The detection limits of the species-specific PCRs for both M. tuberculosis H37Rv and M. abscessus DNA were 5 pg/l (data not shown). The PCR-RLB assay was 10 times more sensitive than the species-specific PCR assays for both M. tuberculosis H37Rv (Fig. 1) and M. abscessus DNA (data not shown); i.e., it was able to detect 500 fg/l. The MYC (genus-specific) probe was more sensitive (50 fg/l) than the MTBC (species-specific) probe for the detection of M. tuberculosis H37Rv (Fig. 1) but was less sensitive (500 fg/l) than the ABS probe (50 fg/l) for the detection of M. abscessus (data not shown).
Specificity of species-specific mycobacterial PCR-RLB assay. PCR amplification with primers Sp1 and Sp2 of DNA from all 78 mycobacterium reference strains produced single bands ranging in length from 200 to 320 bp. The amplicons from the slowly growing Mycobacterium species were smaller (200 to 250 bp) than those from the rapidly growing species (250 to 320 bp). M. xenopi produced the smallest product (ϳ200 bp), and M. gilvum produced the largest product (ϳ320 bp).
There were cross-reactions between the Mycobacterium genus-specific primers (Sp1 and Sp2) and DNA extracts from Nocardia spp. and Rhodococcus spp., which produced two to three copies of the amplicon (Fig. 2) . However the genusspecific probe (MYC) hybridized only with Mycobacterium spp., and with a few exceptions, all species-specific probes hybridized only with the corresponding species. The exceptions were as follows: the probe for M. marinum cross-reacted with 
PCR-RLB assay with clinical isolates of mycobacteria.
A total of 219 clinical isolates were tested "blind" (i.e., without knowledge of the species identity) by the PCR-RLB assay. The PCR-RLB assay was repeated with the few isolates for which there were discrepancies between the results of the PCR-RLB assay and those of GC or HPLC ( Table 2 ). The PCR-RLB assay (including duplicate tests) and sequencing results were identical for all isolates. Three isolates that were identified as members of the M. avium-M. intracellulare complex by GC were identified as M. intracellulare by the PCR-RLB assay. Of 23 isolates identified as M. avium by HPLC, 11 were identified as M. avium, 10 were identified as M. intracellulare, and 2 were identified as M. avium mixed with M. kansasii a/b by the PCR-RLB assay. Of 28 isolates identified as M. chelonae-M. abscessus complex by GC, 26 were identified as M. abscessus, 1 was identified as M. chelonae a/b, and 1 was identified as M. chelonae c by the PCR-RLB assay. Of four isolates identified as M. chelonae by HPLC, three were identified as M. chelonae a/b and one was identified as M. chelonae c by the PCR-RLB assay. Two clinical isolates that had been reported as resembling M. fortuitum by HPLC were shown by the PCR-RLB assay and sequencing to be M. triplex, and the identities of two clinical isolates presumptively identified as M. lentiflavum by HPLC were confirmed to be M. lentiflavum by PCR-RLB and sequencing.
In all, the PCR-RLB assay identified 22 mixed cultures (Table 1). In addition to two with a mixture of M. avium and M. kansasii, there were three in which two potentially pathogenic species were identified: M. chelonae and M. fortuitum, M. tuberculosis complex and M. intracelluare, and M. scrofulaceum and M. intracelluare. Four cultures initially identified as M. gordonae (usually a contaminant) were mixed with another species, and 13 cultures apparently contained mixtures of M. fortuitum subtypes.
DNA from two of the three biopsy specimens from patients with clinical leprosy hybridized with the LEP probe and were confirmed by sequencing to contain M. leprae. The other hybridized with both the MTB and the INT probes, but the sequencing result was uninterpretable, suggesting that both M. tuberculosis and M. intracellulare were present. In addition to this clinical specimen, the PCR-RLB assay identified mixed species in 14 separate clinical isolates and the sequencing results were uninterpretable.
DISCUSSION
In comparison to conventional biochemical methods, GC and HPLC provide rapid results. However, both require expensive instrumentation, reproducible patterns depend on standardized conditions of growth, and interpretation of the results is not always easy. The PCR-RLB assay does not require standardized growth conditions, and it is more accurate and objective than either GC or HPLC. In our study, two clinical isolates which had presumptively been identified as M. fortuitum by HPLC were identified by the PCR-RLB assay as M. triplex, and this result was confirmed by sequencing. The PCR-RLB assay identified mixed mycobacterial cultures which had not been recognized by HPLC or GC and which gave uninterpretable sequencing results. Some previously unidentified species were potentially clinically significant. The finding of four mixed cultures initially identified as containing only M. gordonae indicates that this contaminant Mycobacterium species can mask potential pathogens. It is not clear whether the high proportion of mixed subtypes of M. fortuitum indicates that cross-reactions between probes occur or that mixtures of subtypes commonly occur in nature.
In addition, the PCR-RLB assay was able to discriminate between M. chelonae and M. abscessus, which could not be distinguished by GC, and between M. avium and M. intracellulare, which could not be distinguished by HPLC (Table 1) .
Sequencing of the 16S rRNA gene is often regarded as the "gold standard" for the identification of mycobacteria (5), but it has a demonstrated lower variability with several examples of species difficult to separate from the genus Mycobacterium (10, 25) . Some Mycobacterium species share the same 16S rRNA gene sequence (M. kansasii and M. gastri, M. senegalense and M. farcinogenes) or have very similar 16S rRNA gene sequences (e.g., M. malmoense and M. szulgai) (24) .
The 16S-23S rRNA gene ITS region has been identified as a potentially suitable target for probes that can differentiate closely related species. It contains both conserved and highly variable signatures and is rather small. The 16S-23S rRNA gene ITS-based PCR produces a relatively small PCR product (200 to 350 bp) (Fig. 2) . Roth et al. reported that PCR based on the 16S-23S rRNA gene ITS and restriction fragment length polymorphism (RFLP) analysis is a promising method with advantages over the previously used hsp65 gene-based method for the reliable and easy identification of mycobacteria (19, 20) . However, it has been impeded by difficulties, such as minor differences in band sizes between some species and the occurrence of new patterns not previously reported (17, 27 species within samples. Others have also found that the presence of more than one species in a culture or a clinical sample makes it difficult or impossible to identify the species present by sequencing or RFLP analysis of 16S-23S rRNA gene ITS PCR products (10) .
In our study, from the analysis of 78 reference strains, 219 clinical isolates, and three skin biopsy specimens, the specificity of our PCR-RLB assay, based on the 16S-23S rRNA gene ITS region, was close to 100% (except that M. senegalense reference strain ATCC 35796 reacted with the FOR1 probe). Several other systems that are similar to our PCR-RLB assay system are available: the INNO-LiPA strip (version 2; Immunogenetics) (15, 23, 26) , the GenoType Mycobacterium system (Hain Life Science) (13) , and an oligonucleotide array (16) can identify 16, 13, and 19 Mycobacterium species, respectively. Our PCR-RLB assay based on the 16S-23S rRNA gene ITS can differentiate 34 mycobacterial species and subspecies by the use of 35 probes and has a high degree of specificity.
Our assay is as simple as other reverse hybridization methods, but it is more sensitive because it uses a nonprecipitating enhanced chemiluminescent substrate and Hyperfilm X-ray film. It successfully identified mycobacteria directly in skin biopsy specimens and has the potential to be used for the direct identification of Mycobacterium species from other types of clinical specimens. In addition, it has the advantage that the nylon filters can be stripped and reused at least 30 times and therefore is relatively inexpensive.
In conclusion, the PCR-RLB assay method described here is faster than conventional biochemical tests, is more accurate than HPLC or GC, is less expensive than sequencing, and does not require specialized instrumentation. It is more discriminatory than methods based on 16S rRNA gene-specific PCR or PCR-RFLP analysis of other genes (e.g., rpoB) and identifies more species than other PCR-RLB assays based on the 16S-23S rRNA gene ITS. It has the potential to be used to identify Mycobacterium species directly in clinical specimens.
